This is in agreement with the above–discussed studies reporting that in the mouse asthma model the disease state is characterized by elevated production of both types of eicosanoids [16], [20], and these were inhibited, along with the other disease indices, by inhibition of either sPLA2 or cPLA2. The gene discussed is PLA2G2A; the disease is asthma.